- HO Adami MD
- Dept Medical Epidemiology
- Karolinska Institute, Stockholm, Sweden
- H Bartsch PhD
- Div Toxicology & Cancer Risk Factors
- German Cancer Research Center, Heidelberg, Germany
- P Basset MD PhD
- IGBMC, CNRS, University Strasbourg 1
- Illkirch Graffens, France
- P Beaune
- CHU Necker Enfants Malades, Paris, France
- MJJ Berns PhD
- Dr Daniel Den Hoed Cancer Center
- Dept Medical Oncology, Rotterdam, Netherlands
- H Bohlen MD
- Clinic of Internal Medicine
- University of Cologne, Cologne, Germany
- FX Bosch
- University of Heidelberg, Heidelberg, Germany
- DG Bostwick MD
- Dept Pathology
- Mayo Clinic & Mayo Foundation, Rochester MN
- E Bresnick PhD
- University of Massachusetts Medical Center
- LWK Chung PhD
- Molecular Urology & Therapeutics Program
- University of Virginia School of Medicine, Charlottesville VA
- G de Thé MD
- Unit Epidemiology of Viral Oncogenesis
- Pasteur Institut, Paris, France
- WH Fridman PhD
- Immunology Lab
- Institut Curie, Paris, France
- H Fujiki MD
- Saitama Cancer Center Research Institute, Saitama, Japan
- AM Gerwirtz MD
- Dept Pathology & Laboratory Medicine
- University Pennsylvania, Philadelphia PA
- JB Gibbs PhD
- Merck Sharp & Dohme Ltd, West Point PA
- M Gottardis PhD
- Dept Endocrine Research
- Ligand Pharmaceuticals, San Francisco CA
- DA Haber
- Molecular Genetics Lab
- Massachusetts General Hospital, Cancer Center, Boston MA
- A Harstrick MD
- Dept Internal Medicine, West German Cancer Center, Essen, Germany
- R Hayes
- Division of Cancer Epidemiology and Genetics, National Cancer
Institute, Bethesda MD
- WJM Hrushesky MD
- New York State Department of Health
- Wadsworth Center, Albany NY
- B Huber
- Pharmacology & Molecular Therapeutics,
- Glaxo/Wellcome, Research Triangle Park NC
|
- H Ioachim MD
- Dept Pathology
- Lenox Hill Hospital, New York NY
- NW Kim MD
- Geron Corp, Menlo Pk CA
- P Kleihues MD
- International Agency for Research on Cancer, Lyon, France
- D Li PhD
- Dept Clinical Investigation
- The University of Texas MD Anderson Cancer Center, Houston TX
- L Mao MD
- Dept Thoracic Head & Neck Medical Oncology
- University Texas MD Anderson Cancer Ctr, Houston TX
- F Marincola MD
- National Cancer Institute, Surgical Branch, NIH
- Clinical Oncology Program, Bethesda MD
- T Minamoto
- Kanazawa University, Kanazawa, Japan
- M Nerenberg
- Nanogen, San Diego CA
- D Palli MD
- Epidemiology Unit, CSPO
- Azienda Ospedale Careggi, Florence, Italy
- N Restifo MD
- Surgery Branch
- National Cancer Institute, Bethesda MD
- ZA Ronai PhD
- Ruttenberg Cancer Center
- Mt Sinai Medical Center, New York NY
- AR Sarasin PhD
- CNRS Cancer Research Institute, Villejuif, France
- P Sonneveld MD PhD
- Dept Hematology, University Hospital, Rotterdam, Netherlands
- M Soulilou
- Universite de Rennes I Faculty de Medecine, Rennes, France
- H Tahara
- Lab of Molecular Carcinogenesis
- National Institute of Environmental Health Sciences, Research
Triangle Park NC
- G Thomas MD
- Centre d'Etudes du Polymorphisme Humain, Hopital St Antoine, Paris,
France
- TD Tlsty PhD
- Dept Pathology
- University of California, San Francisco CA
- JM Trent PhD
- Cancer Genetics Lab
- National Center for Human Genome Research, Bethesda MD
- T Tursz ScD MD
- Institut Gustave Roussy, Villejuif, France
- H Vainio MD
- International Agency for Research on Cancer, Lyon, France
- S Waxman MD
- Dept Medicine, Div Neoplastic Diseases
- Mt Sinai Medical Center, New York NY
- IB Weinstein MD
- College of Physicians & Surgeons
- Columbia University, New York NY
- H Yamasaki PhD
- Unit Multistage Carcinogenesis
- International Agency for Research on Cancer, Lyon, France
|